期刊文献+

老年LADA的临床特点分析 被引量:12

Clinical characteristics of senile latent autoimmune diabetes in adults
下载PDF
导出
摘要 目的探讨老年起病(≥60岁)成人隐匿性自身免疫糖尿病(LADA)的临床特点.方法采用回顾性分析方法,对2000年~2003年中南大学湘雅二医院内分泌科住院的846例临床初诊为2型糖尿病(T2DM)患者进行谷氨酸脱羧酶抗体(GAD-Ab)检测,分别比较老年LADA(GAD-Ab阳性)与老年T2DM(GAD-Ab阴性),老年LADA与中青年LADA(15~59岁)的C肽、体重指数(BMI)、HBA1c等.GAD-Ab采用放射配体法,C肽测定采用放射免疫法.结果老年LADA占老年初诊2型糖尿病的8.8%(18/204),中青年LADA占中青年初诊2型糖尿病患者的9.3%(60/642),差异无显著性(P>0.05);老年LADA与老年T2DM比较,C肽、体重指数(BMI)、HBA1c等无统计学差异(P>0.05);老年LADA与中青年LADA比较,C肽水平较高、BMI较大(P<0.05).结论老年LADA占老年初诊2型糖尿病的8.8%,其临床特点与老年T2DM相似,需测定GAD-Ab以利早期分型. Objective: To investigate the clinical characteristics of senile onset (≥60 years old)latent autoimmune diabetes in adults (LADA). Methods: 846 cases of initially diagnosed type 2 diabetes (T2DM), screened by Glutamic acid decarboxylase autoantibodies (GAD-Ab), were analyzed retrospectively in the Second Xiangya Hospital of Central South University from 2000 to 2003. C peptide, BMI, HBA1c etc. were compared between senile LADA and senile T2DM, senile LADA and non-senile LADA (15-59 years old). GAD-Ab and C peptide were measured with radioligand immunoassay and radioimmune assay respectively. Results: No difference in GAD-Ab prevalence was found between senile diabetes (18/204, 8.8%) and non-senile diabetes (60/642, 9.3%); No difference was found in C peptide, BMI, HBA1c between senile LADA and senile T2DM; C peptide level and BMI were higher in senile LADA than non-senile LADA (P <0.05). Conclusions: The prevalence of senile LADA was 8.8% in initially diagnosed senile T2DM, and it was characterized by a similar clinical manifestation to senile T2DM. GAD-Ab screening is necessary for etiological classification in senile diabetes.
出处 《中国现代医学杂志》 CAS CSCD 2004年第13期115-118,共4页 China Journal of Modern Medicine
基金 国家自然科学基金项目(39370343) 卫生部优秀青年科技人才基金项目(Q9420) 国家十五科技攻关项目(2001BA702B04) 教育部跨世纪人才基金项目(2002-48) 湖南省卫生厅科研基金重点项目(2001-Z04)
关键词 老年 成人隐匿性自身免疫糖尿病 胰岛Β细胞功能 谷氨酸脱羧酶抗体 senile latent autoimmune diabetes in adults islet β-cell function glutamic acid decarboxylase autoantibodies
  • 相关文献

参考文献13

二级参考文献31

  • 1潘孝仁,杨文英,肖建中,陈仕明.成人晚发自身免疫性糖尿病的特点及诊断要点探讨[J].中华内科杂志,1997,36(3):159-164. 被引量:67
  • 2王建民,周智广,文建新,伍汉文,ThomasDyrberg.谷氨酸脱羧酶(GAD_(65))自身抗体的放射配体检测法[J].中国糖尿病杂志,1997,5(2):85-88. 被引量:21
  • 3[1]Carlsson A, Sundkvist G, Groop L, et al. Insulin and glucagon secretion in patients with slowly progressing autoimmune diabetes (LADA). J Clin Endocrinol Metab,2000,85:76-80.
  • 4[2]Delerive P, Fruchart JC, Staels B. Peroxisome proliferator-activated receptors in inflammation control. J Endocrinol, 2001, 169:453-459.
  • 5[4]Johansson BL, Brog K, Fernqvist-Forbes E, et al. Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with type 1 diabetes mellitus. Diabet Med, 2000, 17:181-189.
  • 6[5]Di Mario U, Dotta F. Modulation of antigen expression in relation to intervention strategies in type 1 diabetes. Diabete Metab Rev, 1993.245-249.
  • 7[6]Kobayashi T, Nakanishi K, Murase T , et al. Small doses of subcutaneous insulin as a strategy for preventing slowly progressive beta-cell failure in islet cell antibody-positive patients with clinical features of NIDDM. Diabetes, 1996,45:622-626.
  • 8[7]Kobayashi T, Maruyama T, Shimada A, et al. Insulin intervention to preserve β cells in slowly progressive insulin-dependent (type 1) diabetes mellitus. Ann NY Acad Sci, 2002, 958:117-130.
  • 9[8]Beales PE, Pozzilli P. Thiazolidinediones for the prevention of diabetes in the non-obese diabetic (NOD) mouse: implications for human type 1 diabetes. Diabetes Metab Res Rev,2002,18:114-117.
  • 10Tuomi T, Grooop LC, Zimmet PZ, et al. Antibodies to glutarmic acid decarboxylase reveal latent autoimmune diabetes mellltus in adults with noinsulin-dependent onset tfdisease. Diabems, 1993,42:359.

共引文献160

同被引文献63

引证文献12

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部